SCLC Archives - Healthcare Communications Network

HMP CommunicationsFirst-Line Pembrolizumab Combo Improves PFS in Patients w. Extensive-Stage SCLC

The Journal of Clinical Oncology published the double-blind, phase 3 KEYNOTE-604 clinical trial study results, which sought to compare pembrolizumab plus etoposide and platinum (EP) with placebo plus EP in treatment-naïve patients with ES-SCLC.

HMP CommunicationsFDA Approves Lurbinectedin for Adults With Metastatic SCLC

Based on monotherapy data from an open-label, multi-center, single-arm study of 105 adults with platinum-sensitive and platinum-resistant SCLC that progressed after platinum-based chemotherapy, the FDA granted accelerated approval to lurbinectedin (Zepzelca; Jazz Pharmaceuticals and PharmaMar).